Ashland Q4 adjusted profit misses estimates; 2027 sales outlook set higher
Specialty ingredients maker Ashland reported a weaker-than-expected adjusted profit for its fiscal fourth quarter and guided to higher sales for fiscal 2027.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
According to Reuters, Ashland's fiscal fourth-quarter revenue rose 4% to $498 million, slightly below the $501.81 million estimate of eight analysts. Adjusted earnings per share came in at $1.12 against $1.28 expected by ten analysts, up from $1.08 a year earlier. The company posted a net loss of $16 million, compared with net income a year earlier.
Ashland expects fiscal 2027 sales of $1.905 billion to $1.975 billion and adjusted EBITDA of $405 million to $435 million. The company said it anticipates resilient demand in Life Sciences and Personal Care. Higher sales volumes and pricing offset rising raw material costs, while lower productivity at Hopewell and unfavorable absorption weighed on the Specialty Additives segment.
why it matters
The picture for investors is mixed: revenue nearly matched forecasts, but per-share profit clearly disappointed, while the stronger sales outlook rests on growth in two business lines. According to LSEG data, most analysts still rate the shares a buy, with a median 12-month target of $80 against a November 3 close of $73.02.
market impact
Shares of Ashland: weak profit weighs, sales outlook supports, net effect mixed
- Ashland shares mixed — EPS miss and net loss versus a higher fiscal 2027 sales outlook
tags
instruments
sources
- Ashland Q4 adjusted profit misses estimates; forecasts higher 2027 sales — Reuters, 3 November 2026 at 22:34 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗